These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20890581)

  • 21. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
    Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
    Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in biomarkers for the early diagnosis of prostate cancer.
    Cao DL; Yao XD
    Chin J Cancer; 2010 Feb; 29(2):229-33. PubMed ID: 20109357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond PSA: a need for additional markers for prostate cancer.
    Sartor O
    Clin Prostate Cancer; 2004 Dec; 3(3):135. PubMed ID: 15636677
    [No Abstract]   [Full Text] [Related]  

  • 24. Landmarks in prostate cancer diagnosis: the biomarkers.
    Artibani W
    BJU Int; 2012 Oct; 110 Suppl 1():8-13. PubMed ID: 23046035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
    Barichello M; Gion M; Bonazza A; Delli Ponti US; Bolgan A; Contemori GP; Barioli P; Capitanio G; Pecori B; Omacini S
    Eur Urol; 1995; 27(4):295-300. PubMed ID: 7544735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isoforms of free prostate-specific antigen].
    Haese A; Noldus J; Steuber T; Huland H; Lilja H
    Urologe A; 2004 Jun; 43(6):675-9. PubMed ID: 15221148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
    De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
    Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
    Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
    Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen.
    Murphy GP; Barren RJ; Erickson SJ; Bowes VA; Wolfert RL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Kenny GM; Ragde H; Boynton AL; Holmes EH
    Cancer; 1996 Aug; 78(4):809-18. PubMed ID: 8756376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.
    Li W; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Melander O; Ulmert D; Lilja H; Klein RJ
    Prostate; 2020 Dec; 80(16):1405-1412. PubMed ID: 32914890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen.
    Ornstein DK; Pruthi RS
    Expert Opin Pharmacother; 2000 Dec; 1(7):1399-411. PubMed ID: 11249473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.
    McCormack RT; Rittenhouse HG; Finlay JA; Sokoloff RL; Wang TJ; Wolfert RL; Lilja H; Oesterling JE
    Urology; 1995 May; 45(5):729-44. PubMed ID: 7538236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for early prostate cancer detection.
    Margreiter M; Stangelberger A; Valimberti E; Herwig R; Djavan B
    Minerva Urol Nefrol; 2008 Mar; 60(1):51-60. PubMed ID: 18427435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for prostate cancer: prostate-specific antigen and beyond.
    Duffy MJ
    Clin Chem Lab Med; 2020 Feb; 58(3):326-339. PubMed ID: 31714881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers.
    Gumulec J; Masarik M; Krizkova S; Hlavna M; Babula P; Hrabec R; Rovny A; Masarikova M; Sochor J; Adam V; Eckschlager T; Kizek R
    Neoplasma; 2012; 59(2):191-201. PubMed ID: 22248277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
    Beebe-Dimmer JL; Lange LA; Cain JE; Lewis RC; Ray AM; Sarma AV; Lange EM; Cooney KA
    Prostate Cancer Prostatic Dis; 2006; 9(1):50-5. PubMed ID: 16247489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New and novel markers for prostate cancer detection.
    Risk MC; Lin DW
    Curr Urol Rep; 2009 May; 10(3):179-86. PubMed ID: 19371474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
    Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
    J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PSA and PAP as immunohistochemical markers in prostate cancer.
    Epstein JI
    Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.